BioNeutra Global (TSXV:BGA) Debt-to-Equity : -1.23 (As of Dec. 2023)

View and export this data going back to 1999. Start your Free Trial

What is BioNeutra Global Debt-to-Equity?

BioNeutra Global's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$0.46 Mil. BioNeutra Global's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$7.18 Mil. BioNeutra Global's Total Stockholders Equity for the quarter that ended in Dec. 2023 was C$-6.19 Mil. BioNeutra Global's debt to equity for the quarter that ended in Dec. 2023 was -1.23.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for BioNeutra Global's Debt-to-Equity or its related term are showing as below:

TSXV:BGA' s Debt-to-Equity Range Over the Past 10 Years
Min: -6.67 Med: 0.6 Max: 10.09
Current: -1.23

During the past 13 years, the highest Debt-to-Equity Ratio of BioNeutra Global was 10.09. The lowest was -6.67. And the median was 0.60.

TSXV:BGA's Debt-to-Equity is not ranked
in the Consumer Packaged Goods industry.
Industry Median: 0.4 vs TSXV:BGA: -1.23

BioNeutra Global Debt-to-Equity Historical Data

The historical data trend for BioNeutra Global's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNeutra Global Debt-to-Equity Chart

BioNeutra Global Annual Data

Trend

Feb14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

1.60

10.09

-6.67

-1.87

-1.23

BioNeutra Global Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															-1.87	-1.40	-1.10	-0.95	-1.23

Competitive Comparison of BioNeutra Global's Debt-to-Equity

For the Packaged Foods subindustry, BioNeutra Global's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioNeutra Global's Debt-to-Equity Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, BioNeutra Global's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where BioNeutra Global's Debt-to-Equity falls into.

BioNeutra Global Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

BioNeutra Global's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.463	+	7.177)	/	-6.194
	=	-1.23

BioNeutra Global's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.463	+	7.177)	/	-6.194
	=	-1.23

BioNeutra Global (TSXV:BGA) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

BioNeutra Global Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of BioNeutra Global's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

BioNeutra Global (TSXV:BGA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioNeutra Global Corp (TSXV:BGA) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

BGACF:USA

Address

9608 - 25 Avenue NW, Edmonton, AB, CAN, T6N 1J4

Website

http://www.bioneutra.ca

BioNeutra Global Corp is engaged in the research, development, production, and commercialization of food ingredients for neutraceutical, functional and mainstream foods, focusing on oligosaccharides. Its product portfolio provides ingredients for various food systems, that contribute to human nutrition and wellness in functional and healthy foods. Its prime product, VitaFiber IMO, is offered in both powder and syrup form. The company operates in Canada while generating sales revenue from various countries internationally. It has a single industry segment, manufacturing and trading of products. The majority of the revenue is derived from the United States.

BioNeutra Global (TSXV:BGA) Headlines

No Headlines